In the media

• Media attention following our publication and opinion article in The BMJ concerning the added benefit and revenues of anticancer medicines (see publications):
  • 28/02/2024 - News item/press release UU
  • 29/02/2024 - Dr. Lourens Bloem on the Dutch NOS Radio 1 Journaal (radio news)
  • 29/02/2024 - Dr. Lourens Bloem in the Dutch newspaper AD
  • 29/02/2024 - PhD candidate Francine Brinkhuis in the Dutch newspaper Trouw
  • 29/02/2024 - PhD candidate Francine Brinkhuis on Medscape
  • 01/03/2024 - Professor Wim Goettsch on the Dutch BNR (radio news)
  • 12/03/2024 - Interview with dr. Lourens Bloem and PhD candidate Francine Brinkhuis for OncLive
• 20/02/2024 - Interview with PhD candidate Christine van Hattem about our report 'Advanced Therapy Medicinal Products (ATMPs) in the Netherlands: Field Map, Bottleneck Analysis, and Activity Map' (title translated from Dutch; report in Dutch) for the media network Euractiv.
• 05/12/2022 - Interview with dr. Lourens Bloem and dr. Friso Smit about the Regulatory Science workstream of Oncode Accelerator for the Regulatory Science magazine of the Dutch Medicines Evaluation Board.